Report Content
Chapter 1 Methodology & Scope
1.1 Market definition & scope
1.2 Base estimates & calculations
1.2.1 Data collection
1.3 Forecast parameters
1.4 COVID-19 impact analysis at global level
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Global clinical trial supply & logistics industry 3600 synopsis, 2018 – 2032
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Service type trends
2.1.4 Phase trends
2.1.5 Therapeutic area trends
2.1.6 End-use trends
Chapter 3 Clinical Trial Supply & Logistics Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2018 - 2032 (USD Million)
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Increasing number of clinical trials
3.3.1.2 Globalization of clinical trials
3.3.1.3 Increasing outsourcing of clinical trial services
3.3.2 Industry pitfalls & challenges
3.3.2.1 Stringent regulatory requirements and varying regulations
3.3.2.2 Limited infrastructure in developing countries
3.4 Growth potential analysis
3.4.1 By service type
3.4.2 By phase
3.4.3 By therapeutic area
3.4.4 By end-use
3.5 COVID-19 impact analysis
3.6 Technology landscape
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players, 2022
4.4 Competitive positioning matrix, 2022
4.5 Strategic dashboard, 2022
Chapter 5 Clinical Trial Supply & Logistics Market, By Service Type, 2018 - 2032 (USD Million)
5.1 Key trends, by service type
5.2 Logistics & distribution
5.3 Storage & retention
5.4 Packaging, labeling & blinding
5.5 Drug manufacturing
5.6 Comparator sourcing
5.7 Other services
Chapter 6 Clinical Trial Supply & Logistics Market, By Phase, 2018 – 2032 (USD Million)
6.1 Key trends, by phase
6.2 Phase I
6.3 Phase II
6.4 Phase III
6.5 Phase IV
Chapter 7 Clinical Trial Supply & Logistics Market, By Therapeutic Area, 2018 – 2032 (USD Million)
7.1 Key trends, by therapeutic area
7.2 Oncology
7.3 Infectious diseases
7.4 Cardiovascular diseases
7.5 Ophthalmology
7.6 Dermatology
7.7 Autoimmune disease
7.8 Other therapeutic areas
Chapter 8 Clinical Trial Supply & Logistics Market, By End-use, 2018 – 2032 (USD Million)
8.1 Key trends, by end-use
8.2 Pharmaceutical & biotechnology companies
8.3 Contract Research Organizations (CROs)
8.4 Medical device companies
8.5 Other end-users
Chapter 9 Clinical Trial Supply & Logistics Market, By Region, 2018 – 2032 (USD Million)
9.1 Key trends, by region
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest of Latin America
9.6 MEA
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 Rest of MEA
Chapter 10 Company Profiles
10.1 Thermo Fisher Scientific Inc. (Patheon)
10.2 Catalent, Inc.
10.3 Parexel
10.4 Almac Group
10.5 Marken
10.6 Piramal Pharma Solutions
10.7 UDG Healthcare
10.8 DHL
10.9 Movianto
10.10 Packaging Coordinators Inc.
